Back to Beacon Pointe Advisors, LLC Beacon Pointe Advisors, LLC

ADMAADMA
9 quarters

Position history for Beacon Pointe Advisors, LLCBeacon Pointe Advisors, LLC's holdings in ADMA BIOLOGICS INC

No. Beacon Pointe Advisors exited its ADMA (Adma Biologics) position in Q2 2024. Its Q1 2024 13F listed 10,653 shares worth $70,310. Beacon Pointe Advisors first reported ADMA in Q4 2021 and held it in 6 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$39,000

Total Shares Change

-27,950

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%$11.18
0
2024-Q1
New
10,653
-
$70,3100.0%$6.60
29
2023-Q2
Exited
0
-100.0%
$00.0%$3.69
0
2023-Q1
Decreased
14,915
-0.3%
$49,3690.0%$3.31
0
2022-Q4
Unchanged
14,960
0.0%
$58,0450.0%$3.88
0
2022-Q3
New
14,960
-
$36,0000.0%$2.43
28
2022-Q2
Exited
0
-100.0%
$00.0%$1.98
0
2022-Q1
Decreased
23,490
-16.0%
$43,0000.0%$1.83
0
2021-Q4
New
27,950
-
$39,0000.0%$1.41
28

Other major holders of ADMA: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used